ALIGOS THERAPEUTICS INC (ALGS)
US01626L1052 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 24.15M | 135.70M | 81.30M | 186.80M | 220.40M | |||
| Marketable Securities | 88.59M | 0.00 | 44.50M | 3.90M | 23.10M | |||
| Other Current Assets | 5.33M | 5.38M | 7.70M | 13.70M | 6.50M | |||
| Total Current Assets | 118.06M | 141.08M | 133.50M | 204.40M | 250.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 9.21M | 9.82M | 12.50M | 15.00M | 14.90M | |||
| Investments And Advances | N/A | N/A | 0.00 | 15.10M | N/A | |||
| Other Non-Current Assets | 625.00K | 625.00K | 600.00K | 900.00K | 400.00K | |||
| Total Non-Current Assets | 9.84M | 10.44M | 13.20M | 31.00M | 15.30M | |||
| TOTAL ASSETS | 127.90M | 151.53M | 146.70M | 235.40M | 265.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 5.00K | 10.00K | 100.00K | 100.00K | 100.00K | |||
| Accrued Expenses | 12.47M | 17.05M | 17.50M | 26.70M | 18.30M | |||
| Accounts Payable | 2.84M | 2.52M | 4.70M | 3.00M | 3.30M | |||
| Other Current Liabilities | 3.56M | 4.33M | 10.70M | 9.20M | 8.60M | |||
| Total Current Liabilities | 18.88M | 23.91M | 33.10M | 39.00M | 30.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 217.00K | 231.00K | 200.00K | 400.00K | 500.00K | |||
| Other Non-Current Liabilities | 49.01M | 35.31M | 9.40M | 11.30M | 14.50M | |||
| Total Non-Current Liabilities | 49.23M | 35.54M | 9.70M | 11.60M | 15.00M | |||
| TOTAL LIABILITIES | 68.11M | 59.45M | 42.80M | 50.60M | 45.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -521.66M | -486.80M | -399.10M | -303.10M | -174.70M | |||
| Additional Paid In Capital | 580.97M | 578.33M | 502.60M | 487.30M | 395.00M | |||
| Common Shares | 7.00K | 7.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 476.00K | 545.00K | 400.00K | 500.00K | -200.00K | |||
| Shares Outstanding | 78.76M | 75.67M | 42.90M | 42.70M | 39.70M | |||
| Tangible Book Value per Share | 0.76 | 1.22 | 2.42 | 4.33 | 5.54 | |||
| Total Shareholders' Equity | 59.80M | 92.08M | 103.90M | 184.70M | 220.00M | |||
| TOTAL LIABILITIES AND EQUITY | 127.90M | 151.53M | 146.70M | 235.40M | 265.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Ratio | 6.25 | 5.90 | 4.03 | 5.24 | 8.25 | |||
| Return On Assets (ROA) | -77.86% | -57.86% | -65.47% | -54.52% | -40.91% | |||
| Return On Equity (ROE) | -166.54% | -95.22% | -92.44% | -69.48% | -49.34% | |||
All data in USD